recurrent Dermatofibrosarcoma protuberans
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
Desmoid Tumors
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
Hypereosinophilic Syndrome (HES)
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
Refractory Acute Lymphoblastic Leukemia (ALL)
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
Leukemia
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
FIP1L1-PDGFRα fusion kinase status unknown Chronic eosinophilic leukemia
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
Myeloproliferative Disorders (MPD)
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
Chordomas
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
allogeneic hematopoietic stem cell transplant
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
FIP1L1-PDGFRα fusion kinase status unknown Hypereosinophilic syndrome
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
metastatic Dermatofibrosarcoma protuberans
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
Myelodysplastic Syndrome
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
refractory, chronic phase Chronic myeloid leukemia
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
Mastocytosis, Systemic
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
Blast Phase
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
Eosinophilic leukemia
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
newly diagnosed, chronic phase Chronic myeloid leukemia
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
Metastatic Gastrointestinal Stromal Tumor
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
systemic mastocytosis with associated hematological neoplasm
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution
refractory, accelerated phase Chronic myeloid leukemia
400.0 mg, , 100.0 mg, 80.0 mg/mL, 50.0 mg
Tablet, coated - Oral, , Tablet, film coated - Oral, Tablet, coated, Oral, Capsule - Oral, Tablet - Oral, Solution - Oral, Tablet, film coated, Tablet, Capsule, Solution